Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.
Identifieur interne : 004395 ( PubMed/Corpus ); précédent : 004394; suivant : 004396Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.
Auteurs : B. Nanda ; K. KrishnamoorthySource :
- Tropical medicine & international health : TM & IH [ 1360-2276 ] ; 2003.
English descriptors
- KwdEn :
- Acute Disease, Chronic Disease, Cost of Illness, Elephantiasis, Filarial (economics), Elephantiasis, Filarial (epidemiology), Elephantiasis, Filarial (therapy), Female, Health Care Costs, Humans, India (epidemiology), Male, Patient Acceptance of Health Care (statistics & numerical data), Urban Health.
- MESH :
- geographic , epidemiology : India.
- economics : Elephantiasis, Filarial.
- epidemiology : Elephantiasis, Filarial.
- statistics & numerical data : Patient Acceptance of Health Care.
- therapy : Elephantiasis, Filarial.
- Acute Disease, Chronic Disease, Cost of Illness, Female, Health Care Costs, Humans, Male, Urban Health.
Abstract
Previous estimates on the economic burden of lymphatic filariasis (LF) in India and elsewhere were primarily based on studies in rural areas. We investigated the treatment costs due to acute and chronic forms of LF in urban areas, where nearly one-third of the affected people live. Almost 98% of the patients with acute episodes of adenolymphangitis (ADL) underwent treatment and 49% of chronic patients also received treatment. The average treatment cost per ADL episode (n = 108) was Rs 22.21 +/- 53.84 (US dollars 0.46 +/- 1.12). The overall (n = 200) treatment costs incurred by a chronic patient per visit were Rs 16.71 +/- 62.36 (US dollars 0.35 +/- 1.30); for those who paid (n = 98) they were Rs 34.10 +/- 85.90 (US dollars$ 0.71 +/- 1.79). These costs are considerably higher than in rural areas. Government health centres and private practitioners were important sources of treatment. Treatments received from private practitioners were considerably more expensive than those from government health facilities. The cost of medicine accounted for 44% and 50% of the total expenditure on treatment for acute and chronic disease patients, respectively. The medical personnel from these treatment sources need to be trained on the new morbidity management methods, which are likely to be more effective than the current methods of treatment.
PubMed: 12535251
Links to Exploration step
pubmed:12535251Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.</title>
<author><name sortKey="Nanda, B" sort="Nanda, B" uniqKey="Nanda B" first="B" last="Nanda">B. Nanda</name>
<affiliation><nlm:affiliation>Vector Control Research Centre, Pondicherry, India. vcrc@vsnl.com</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Krishnamoorthy, K" sort="Krishnamoorthy, K" uniqKey="Krishnamoorthy K" first="K" last="Krishnamoorthy">K. Krishnamoorthy</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:12535251</idno>
<idno type="pmid">12535251</idno>
<idno type="wicri:Area/PubMed/Corpus">004395</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004395</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.</title>
<author><name sortKey="Nanda, B" sort="Nanda, B" uniqKey="Nanda B" first="B" last="Nanda">B. Nanda</name>
<affiliation><nlm:affiliation>Vector Control Research Centre, Pondicherry, India. vcrc@vsnl.com</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Krishnamoorthy, K" sort="Krishnamoorthy, K" uniqKey="Krishnamoorthy K" first="K" last="Krishnamoorthy">K. Krishnamoorthy</name>
</author>
</analytic>
<series><title level="j">Tropical medicine & international health : TM & IH</title>
<idno type="ISSN">1360-2276</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acute Disease</term>
<term>Chronic Disease</term>
<term>Cost of Illness</term>
<term>Elephantiasis, Filarial (economics)</term>
<term>Elephantiasis, Filarial (epidemiology)</term>
<term>Elephantiasis, Filarial (therapy)</term>
<term>Female</term>
<term>Health Care Costs</term>
<term>Humans</term>
<term>India (epidemiology)</term>
<term>Male</term>
<term>Patient Acceptance of Health Care (statistics & numerical data)</term>
<term>Urban Health</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Patient Acceptance of Health Care</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Acute Disease</term>
<term>Chronic Disease</term>
<term>Cost of Illness</term>
<term>Female</term>
<term>Health Care Costs</term>
<term>Humans</term>
<term>Male</term>
<term>Urban Health</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Previous estimates on the economic burden of lymphatic filariasis (LF) in India and elsewhere were primarily based on studies in rural areas. We investigated the treatment costs due to acute and chronic forms of LF in urban areas, where nearly one-third of the affected people live. Almost 98% of the patients with acute episodes of adenolymphangitis (ADL) underwent treatment and 49% of chronic patients also received treatment. The average treatment cost per ADL episode (n = 108) was Rs 22.21 +/- 53.84 (US dollars 0.46 +/- 1.12). The overall (n = 200) treatment costs incurred by a chronic patient per visit were Rs 16.71 +/- 62.36 (US dollars 0.35 +/- 1.30); for those who paid (n = 98) they were Rs 34.10 +/- 85.90 (US dollars$ 0.71 +/- 1.79). These costs are considerably higher than in rural areas. Government health centres and private practitioners were important sources of treatment. Treatments received from private practitioners were considerably more expensive than those from government health facilities. The cost of medicine accounted for 44% and 50% of the total expenditure on treatment for acute and chronic disease patients, respectively. The medical personnel from these treatment sources need to be trained on the new morbidity management methods, which are likely to be more effective than the current methods of treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12535251</PMID>
<DateCreated><Year>2003</Year>
<Month>01</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted><Year>2003</Year>
<Month>04</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1360-2276</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>1</Issue>
<PubDate><Year>2003</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Tropical medicine & international health : TM & IH</Title>
<ISOAbbreviation>Trop. Med. Int. Health</ISOAbbreviation>
</Journal>
<ArticleTitle>Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India.</ArticleTitle>
<Pagination><MedlinePgn>56-9</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Previous estimates on the economic burden of lymphatic filariasis (LF) in India and elsewhere were primarily based on studies in rural areas. We investigated the treatment costs due to acute and chronic forms of LF in urban areas, where nearly one-third of the affected people live. Almost 98% of the patients with acute episodes of adenolymphangitis (ADL) underwent treatment and 49% of chronic patients also received treatment. The average treatment cost per ADL episode (n = 108) was Rs 22.21 +/- 53.84 (US dollars 0.46 +/- 1.12). The overall (n = 200) treatment costs incurred by a chronic patient per visit were Rs 16.71 +/- 62.36 (US dollars 0.35 +/- 1.30); for those who paid (n = 98) they were Rs 34.10 +/- 85.90 (US dollars$ 0.71 +/- 1.79). These costs are considerably higher than in rural areas. Government health centres and private practitioners were important sources of treatment. Treatments received from private practitioners were considerably more expensive than those from government health facilities. The cost of medicine accounted for 44% and 50% of the total expenditure on treatment for acute and chronic disease patients, respectively. The medical personnel from these treatment sources need to be trained on the new morbidity management methods, which are likely to be more effective than the current methods of treatment.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nanda</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Vector Control Research Centre, Pondicherry, India. vcrc@vsnl.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krishnamoorthy</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Trop Med Int Health</MedlineTA>
<NlmUniqueID>9610576</NlmUniqueID>
<ISSNLinking>1360-2276</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N" Type="Geographic">India</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014504" MajorTopicYN="N">Urban Health</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2003</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2003</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>4</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">12535251</ArticleId>
<ArticleId IdType="pii">962</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004395 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004395 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:12535251 |texte= Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:12535251" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |